Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-17 4:22 pm Purchase | 2025-11-13 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 1,670,081 9.900% | 44,403 (+2.73%) | Filing History |
| 2025-11-14 8:08 pm Purchase | 2025-09-30 | 13G | Marker Therapeutics, Inc. MRKR | Alyeska Investment Group L.P. | 1,280,952 9.900% | 211,293 (+19.75%) | Filing History |
| 2025-08-20 4:58 pm Sale | 2025-08-19 | 13D | Marker Therapeutics, Inc. MRKR | Wilson John Robert | 641,801 4.960% | -18,100 (-2.74%) | Filing History |
| 2025-08-19 2:42 pm Purchase | 2025-08-15 | 13D | Marker Therapeutics, Inc. MRKR | Wilson John Robert | 659,901 5.100% | 659,901 (New Position) | Filing History |
| 2025-08-18 5:34 pm Unchanged | 2025-08-14 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 1,625,678 12.600% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | Marker Therapeutics, Inc. MRKR | Blue Owl Capital Holdings LP | 1,127,052 9.990% | 572,802 (+103.35%) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | Marker Therapeutics, Inc. MRKR | Blue Owl Capital Holdings LP | 554,250 5.180% | 554,250 (New Position) | Filing History |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | Marker Therapeutics, Inc. MRKR | Alyeska Investment Group L.P. | 1,069,659 9.990% | 1,069,659 (New Position) | Filing History |
| 2024-12-23 4:30 pm Purchase | 2024-12-19 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 1,625,678 15.200% | 1,625,678 (New Position) | Filing History |
| 2024-05-17 6:25 pm Unchanged | 2024-05-17 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-03 4:30 pm Unchanged | 2023-03-03 | 13D | Marker Therapeutics, Inc. MRKR | Aisling Capital IV LP | 0 0.000% | 0 (Unchanged) | Filing |